{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-094174","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2026-08-27T13:05:14+00:00","discovered_at":"2026-08-27T13:06:00.288121+00:00","generated_at":"2026-08-27T13:06:03.462983+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NeuroOne reports successful large-animal StereoCED procedures; human studies planned this quarter","bullets":["Three large-animal procedures completed using next-gen StereoCED platform at University of Minnesota.","In two procedures, drug delivery electrodes delivered study agent and recorded intracranial electrophysiological activity from same regions.","Robotic platform used for trajectory, drilling, and anchor bolt placement; drug delivery and recording successful.","StereoCED revenue expected in fiscal Q4 2026; human investigational device release planned by end of Q4 2026.","CEO Dave Rosa cites repeatability and progress toward human investigational clinical studies later this quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-094174","json":"https://secwatch.observer/filing/0001213900-26-094174.json","markdown":"https://secwatch.observer/filing/0001213900-26-094174.md","text":"https://secwatch.observer/filing/0001213900-26-094174.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026094174/0001213900-26-094174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026094174/ea0303530-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-27T13:06:03.462983+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}